HER 2.0
Award: Shortlist
Shortlist / Pharma / Branding / 2024
HER2 is a receptor on cancer cells that propels tumor growth and is synonymous with hope among oncologists. HER2 is one of the most widely accepted targets for treatment, but only in breast cancer. For more insidious stomach cancers, these drugs have fallen short. The lack of innovation has meant a great loss of hope. Until now. Jazz Pharmaceuticals is developing a new precision medicine that will finally open the promise of HER2 to stomach cancers. Our poster campaign, HER2.0, targets oncologists at medical conferences to generate interest and excitement for the next era of HER2 treatment.
